Cost-effectiveness evaluation of rapid initiation of antiretroviral therapy based on decision-tree Markov model

被引：0
|
作者：
Guan, Yuan [1 ,2 ]
Tang, Qi [1 ,3 ]
Zhu, Han [4 ]
Liu, Danping [3 ]
Qi, Tangkai [3 ]
Zhang, Renfang [3 ]
Chen, Jun [3 ]
Liu, Li [3 ]
Shen, Yinzhong [3 ]
Lu, Hongzhou [2 ]
机构：
[1] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China
[2] Shenzhen Third Peoples Hosp, Natl Clin Res Ctr Infect Dis, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518100, Guangdong, Peoples R China
[3] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Infect & Immun, Shanghai 201508, Peoples R China
[4] Songjiang Dist Ctr Dis Control & Prevent, Shanghai 201620, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 08期
关键词：
D O I：
10.1097/CM9.0000000000002659
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：986 / 988
页数：3
相关论文
共 50 条
  • [31] Cost-effectiveness of treatment alternatives in Parkinson's disease. An evaluation using a Markov decision analytic model
    Dodel, R
    Spottke, A
    Oertel, WH
    Poewe, W
    Sampaio, C
    Siebert, U
    MOVEMENT DISORDERS, 2002, 17 : S4 - S4
  • [32] Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Cote d'Ivoire: A model-based analysis
    Ouattara, Eric N.
    MacLean, Rachel L.
    Danel, Christine
    Borre, Ethan D.
    Gabillard, Delphine
    Huang, Mingshu
    Moh, Raoul
    Paltiel, A. David
    Eholie, Serge P.
    Walensky, Rochelle P.
    Anglaret, Xavier
    Freedberg, Kenneth A.
    PLOS ONE, 2019, 14 (06):
  • [33] THE COST-EFFECTIVENESS OF HIGH-DOSE INTRAVENOUS ESOMEPRAZOLE IN PEPTIC ULCER BLEEDING: A DECISION-TREE MODEL WITH SPANISH COSTS AND NEW CLINICAL DATA
    Barkun, A.
    Adam, V
    Sung, J. J.
    Kuipers, E.
    Moessner, J.
    Jensen, D.
    Stuart, R. C.
    Lau, J. Y.
    Naucler, E.
    Kilhamn, J.
    Granstedt, H.
    Liljas, B.
    Lind, T.
    VALUE IN HEALTH, 2008, 11 (06) : A520 - A520
  • [34] Cost-effectiveness of social freezing in Germany - estimates based on a Markov model
    Ziller, V.
    Klueber, C.
    Kruger, F. P.
    Wagner, U.
    HUMAN REPRODUCTION, 2016, 31 : 287 - 287
  • [35] Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model
    Fiddelers, Audrey A. A.
    Dirksen, Carmen D.
    Dumoulin, John C. M.
    van Montfoort, Aafke P. A.
    Land, Jolande A.
    Janssen, J. Marij
    Evers, Johannes L. H.
    Severens, Johan L.
    HUMAN REPRODUCTION, 2009, 24 (07) : 1648 - 1655
  • [36] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    Jiang, Junhong
    Congdon, Nathan
    LANCET GLOBAL HEALTH, 2019, 7 (07): : E968 - E978
  • [37] Cost-effectiveness and cost-utility of population-based glaucoma screening in China: A decision-analytic Markov model
    Congdon, Nathan G.
    Tang, Jianjun
    Liang, Yuanbo
    O'Neill, Ciaran
    Kee, Frank
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [38] Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial
    Jamieson, Lise
    Serenata, Celicia
    Makhubele, Lebogang
    Sokhela, Simiso
    Mashabane, Nkuli
    Akpomiemie, Godspower
    Johnson, Leigh F.
    Venter, Willem D. F.
    Meyer-Rath, Gesine
    AIDS, 2021, 35 : S173 - S182
  • [39] Decision-tree sensitivity analysis for cost-effectiveness of FDG-PET in patients with non-small-cell lung carcinoma
    Kosuda, S
    Ichihara, K
    Watanabe, M
    Kobayashi, H
    Kusano, S
    POSITRON EMISSION TOMOGRAPHY IN THE MILLENNIUM, 2000, 1197 : 187 - 190
  • [40] THE COST-EFFECTIVENESS OF HYPERTENSION PHARMACOTHERAPY IN SERBIA: A MARKOV MODEL
    Lakic, Dragana
    Petrova, Guenka
    Bogavac-Stanojevic, Natasa
    Jelic-Ivanovic, Zorana
    Kos, Mitja
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2012, 26 (03) : 3066 - 3072
12345